• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAUSCH + LOMB BAUSCH + LOMB INJECTOR SYSTEM CARTRIDGE; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAUSCH + LOMB BAUSCH + LOMB INJECTOR SYSTEM CARTRIDGE; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL) Back to Search Results
Model Number BLIS-X1
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Blurred Vision (2137); No Code Available (3191)
Event Date 01/30/2020
Event Type  Injury  
Manufacturer Narrative
The reporter has indicated the injector is not available for return.The investigation is in progress.A follow up report will be submitted as additional information is received.
 
Event Description
It was reported that during surgery, the surgeon noticed that the intraocular lens (iol) implanted into the left (os) eye, appeared to have a scratch on the optic.The lens was removed and replaced intraoperatively with an iol of the same model and diopter.The second iol implanted successfully.There was no damage to the capsular bag, no loss of vitreous.There was no vitrectomy and the plan of surgery did not change.However, the incision was enlarged in order to remove the lens and sutures were required.In the physician's opinion, the most likely cause of the iol damage was forceps/handling.The patient's current prognosis was blurry vision at 24hrs.At 48 hrs, vision was improving.The doctor has continued to monitor and the patient is doing very well and the vision has improved immensely.
 
Manufacturer Narrative
The product was not returned for evaluation as it was discarded by the user facility.Per the reporter, the event is believed to be related to product handling.A device history record (dhr) review could not be performed as no lot number had been provided.The trend analysis, risk analysis and directions for use review are considered acceptable, with the product performing within anticipated rates.Damage to the intraocular lens (iol) may be rooted in the loading procedure.An insufficient amount of viscoelastic could be the cause of the issue.Additionally, improper manipulation using hard tip plungers is a common root cause for scratches on the optic.No corrective action is necessary at this time.
 
Event Description
Further clarification was received from the account that forceps were not used but the event is believed to be related to product handling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BAUSCH + LOMB INJECTOR SYSTEM CARTRIDGE
Type of Device
FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)
Manufacturer (Section D)
BAUSCH + LOMB
1400 north goodman street
rochester NY 14609
MDR Report Key9757805
MDR Text Key183917240
Report Number0001313525-2020-00044
Device Sequence Number1
Product Code MSS
Combination Product (y/n)Y
PMA/PMN Number
K131958
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 01/01/2005,02/03/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberBLIS-X1
Device Catalogue NumberBLIS-X1
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Initial Date Manufacturer Received 02/03/2020
Initial Date FDA Received02/26/2020
Supplement Dates Manufacturer Received03/23/2020
Supplement Dates FDA Received04/15/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
OCUCOAT VISCOELASTIC, ENVISTA INTRAOCULAR LENS
Patient Outcome(s) Required Intervention;
Patient Age84 YR
-
-